Abstract

Digital biodetection is one of the most ultrasensitive methods for quantifying biomarkers and has aroused extensive attention in biomedical fields. However, most of digital biodetections need a large number of isolated micro-chambers (such as microarrays or micro-droplets) at femtoliter or microliter scale to form a single target molecule reactor, which is complicated for practical applications. Here we propose a simple, micro-chamber free digital biodetection method via replacing micro-chambers with microspheres for the first time by employing magnetic spheres (MSs) as carriers and fluorescent particles (FPs) as labels (that is “sphere-labeled-sphere” strategy). An ideal model digital biodetection is first conducted to verify the feasibility and accuracy of our strategy through flow cytometry (FCM). After a systematic investigation of size effects on detection performance, 1.2 μm fluorescent polystyrene spheres (PSs) are determined to be the optimal labels for the carriers of 3.2 μm MSs. Finally, the test of carcinoembryonic antigen (CEA) was performed as a proof of concept, which displays a more objective and accurate result for distinguishing positive signals from negative ones. Therefore, this novel micro-chamber free digital biodetection method via the “sphere-labeled-sphere” strategy paves a promising way as a precise and powerful methodological tool for ultrasensitive biomarkers detection.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.